A comprehensive narrative review from the University of Szeged maps vitamin C's interactions across the canonical hallmarks of aging — including epigenetic dysregulation, mitochondrial dysfunction, chronic inflammation, and cellular stress responses — concluding that ascorbic acid functions as a context-dependent modulator of cellular resilience rather than a broad anti-aging agent. The authors emphasize that mechanistic evidence is largely confined to in vitro and preclinical models, with human data remaining observational and interventional confirmation scarce.
This is a well-framed but ultimately confirmatory review that crystallizes a frustrating gap in micronutrient longevity research: compelling cellular mechanisms rarely survive translation to robust human endpoints. Vitamin C's role in collagen hydroxylation, TET-enzyme-mediated DNA demethylation, and NF-κB suppression is well-documented in cell culture, yet randomized trials have repeatedly failed to show mortality or healthspan benefits in replete populations. The authors' framing — that benefits are most plausible under deficiency, inflammation, or elevated oxidative load — is scientifically defensible and practically important, since subclinical deficiency is surprisingly prevalent in older adults, smokers, and hospitalized patients. For longevity-focused adults, the actionable takeaway is modest but real: ensuring adequate plasma ascorbate (≥50 µmol/L) may matter more than megadosing. The review's honest acknowledgment of heterogeneous evidence elevates it above typical supplement advocacy, though its narrative design limits causal inference. Incremental in contribution, but useful as a mechanistic roadmap for future biomarker-anchored intervention trials.
